Bitcoin price today: little changed near $119k ahead of Fed meet, tariff deadline
Coca-Cola (NYSE:KO) Europacific Partners plc (NASDAQ:CCEP), a company with annual revenue of nearly $11 billion and a "GOOD" Financial Health score according to InvestingPro, reported Monday that it repurchased a total of 53,344 of its own ordinary shares on June 30, 2025, as part of its ongoing share buyback program. The transactions were disclosed in a statement based on a press release and filed with the U.S. Securities and Exchange Commission.
According to the filing, the company acquired 38,463 ordinary shares on U.S. trading venues, including NASDAQ, and 14,881 ordinary shares on London trading venues, which comprise the London Stock Exchange (LON:LSEG) and CBOE Europe Limited (CXE and BXE). The repurchased shares will be cancelled. The company maintains a healthy current ratio of 1.56, indicating strong liquidity to support its buyback program.
The highest price paid per ordinary share on the U.S. trading venues was $92.52, and the lowest was $91.02. The volume-weighted average price paid was $91.91 per share. On the London trading venues, the highest price paid per ordinary share was £67.20, with a lowest price of £66.40. The volume-weighted average prices on the London venues ranged from £66.78 to £66.79 per share.
These purchases are part of a share buyback program announced on February 14, 2025, under which the company expects to repurchase up to €1 billion of its ordinary shares.
Coca-Cola Europacific Partners is listed on Euronext (EPA:ENX) Amsterdam, NASDAQ, the London Stock Exchange, and the Spanish Stock Exchanges under the symbol CCEP.
All information is based on a press release statement and the company’s SEC filing.
In other recent news, Coca-Cola Europacific Partners has continued its share buyback program, executing purchases on both US and London trading venues. The company reported acquiring shares on multiple dates in June 2025, with the highest price paid per share reaching $94.58 in the US and £69.50 in London. These transactions are part of a larger buyback initiative announced earlier this year, targeting up to €1 billion in ordinary shares. Meanwhile, LATAM Airlines (NYSE:LTM) Group has entered into an underwriting agreement with J.P. Morgan Securities LLC and several shareholders for the sale of its common shares. This agreement, detailed in an SEC filing, is part of the airline’s ongoing financial activities. GH Research has scheduled its annual general meeting for July 31, 2025, in Dublin, Ireland, with proxy materials and agenda items made available to shareholders. Sinovac Biotech has announced a special shareholder meeting set for July 8, 2025, though specific agenda items have not been disclosed. Additionally, Riskified (NYSE:RSKD) Ltd. will hold its Annual General Meeting of Shareholders on August 6, 2025, in Tel Aviv, providing proxy materials for voting.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.